BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37164914)

  • 1. Role of ALOX5 in non-small cell lung cancer: A potential therapeutic target associated with immune cell infiltration.
    Zhao Q; Sun Z; Pan Y; Jing Q; Li W; Wang C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):311-322. PubMed ID: 37164914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
    Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of the Significance of Immune Cell Infiltration and Prognosis of Non-Small-Cell Lung Cancer by Bioinformatics.
    Sun H; Sui B; Li Y; Yan J; Cao M; Zhang L; Liu S
    J Healthc Eng; 2021; 2021():3284186. PubMed ID: 34603645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
    Wu Z; You C; Zhu Z; Wu W; Cao J; Xie Q; Deng C; Huang X; Hu S
    Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):427-440. PubMed ID: 37688682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of T Cell-Related Long Noncoding RNA-MicroRNA-mRNA Regulatory Networks in Non-Small-Cell Lung Cancer.
    Duan J; Pan Y; Yang X; Zhong L; Jin Y; Xu J; Zhuang J; Han S
    Biomed Res Int; 2020; 2020():5816763. PubMed ID: 33274216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. POLE2 Serves as a Prognostic Biomarker and Is Associated with Immune Infiltration in Squamous Cell Lung Cancer.
    Wu Z; Wang YM; Dai Y; Chen LA
    Med Sci Monit; 2020 Apr; 26():e921430. PubMed ID: 32304567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.
    Fan K; Zhang BH; Han D; Sun YC
    BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
    Zhu G; Li Y; Shi R; Xu S; Zhang Z; Cao P; Chen C; Liu H; Chen J
    Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):236-244. PubMed ID: 33910272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying the hub genes in non-small cell lung cancer by integrated bioinformatics methods and analyzing the prognostic values.
    Wang T; Chen X; Jing F; Li Z; Tan H; Luo Y; Shi H
    Pathol Res Pract; 2021 Dec; 228():153654. PubMed ID: 34749208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Expression of
    Chen Y; Zhou M; Gu X; Wang L; Wang C
    Dis Markers; 2022; 2022():8789515. PubMed ID: 35855850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of RILPL2 and its correlation with tumor immune microenvironment and glycolysis in non-small cell lung cancer.
    Chen D; Zhang H; Zhao L; Liu X; Xue S; Wu P; Jiang H
    Cell Cycle; 2023 Apr; 22(7):841-857. PubMed ID: 36536539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of TIMELESS and RORA as key clock molecules of non-small cell lung cancer and the comprehensive analysis.
    Xian H; Li Y; Zou B; Chen Y; Yin H; Li X; Pan Y
    BMC Cancer; 2022 Jan; 22(1):107. PubMed ID: 35078435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the expression and prognosis for leukocyte immunoglobulin-like receptor subfamily B in human liver cancer.
    Fan J; Wang L; Chen M; Zhang J; Li J; Song F; Gu A; Yin D; Yi Y
    World J Surg Oncol; 2022 Mar; 20(1):92. PubMed ID: 35321724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative Multi-Omics Analysis of Identified NUF2 as a Candidate Oncogene Correlates With Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer.
    Chen M; Li S; Liang Y; Zhang Y; Luo D; Wang W
    Front Oncol; 2021; 11():656509. PubMed ID: 34178642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression signature, prognosis value and immune characteristics of cathepsin F in non-small cell lung cancer identified by bioinformatics assessment.
    Song L; Wang X; Cheng W; Wu Y; Liu M; Liu R; Zhang S; Xia H; Liu H; Tai X; Zhao H; Li X; Ji F
    BMC Pulm Med; 2021 Dec; 21(1):420. PubMed ID: 34923982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Analysis of the Prognostic Significance and Roles of the Integrin Alpha Family in Non-Small Cell Lung Cancers.
    Huang Y; Guo DM; Bu S; Xu W; Cai QC; Xu J; Jiang YQ; Teng F
    Adv Ther; 2023 May; 40(5):2186-2204. PubMed ID: 36892810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of the correlation between the expression of WFDC2 in B cells of lung adenocarcinoma tissue and the survival rate of patients].
    Zhang H; Lu J; Yang Y; Wang L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 May; 35(5):425-433. PubMed ID: 31223112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Regulatory Network and Potential Role of LINC00973-miRNA-mRNA ceRNA in the Progression of Non-Small-Cell Lung Cancer.
    Guo Q; Li D; Luo X; Yuan Y; Li T; Liu H; Wang X
    Front Immunol; 2021; 12():684807. PubMed ID: 34394080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.